Latest NRx Pharmaceuticals News & Updates

See the latest news and media coverage for NRx. We track all announcements, press releases, and industry mentions in real time, all in one place.

NRx Pharmaceuticals (NRx)

Clinical-stage biopharmaceutical company developing treatments for severe mental health conditions

nrxpharma.com

Headquarters: Wilmington, United States
Founded year: 2015
Company type: Private company
Number of employees: 19–50
Industry: Pharmaceuticals

Last updated Yesterday

Latest news about NRx Pharmaceuticals (NRx)

In short: NRx advanced preservative-free ketamine toward an FDA decision and secured an $11 million DARPA contract.

Company announcements

Yesterday NRx

NRx receives FDA approval for preservative-free ketamine

The company announces US manufacturing reshoring of sterile injectable drugs.

August 17 NRx

NRx reports Q2 2026 financial results and operational milestones

The company secured $22.3 million via public offering, won a DARPA contract for NRX-101, advanced preservative-free ketamine approval, appointed a CCO, and reduced net losses.

May 18 NRx

NRx reports Q1 2026 financial results and provides corporate update

The company announced a $1.4 million net loss, FDA milestones for NRX-100, and an IND acceptance for NRX-101 alongside subsidiary expansions.

March 24 NRx

NRx reports full-year 2025 results and highlights regulatory progress

The company reduced operating losses to $16.2 million while maintaining $7.8 million in cash. NRx anticipates FDA approval for Preservative Free Ketamine during Q3 2026.

Media coverage

Yesterday Seeking Alpha

NRx Pharma wins FDA nod for generic ketamine (NRXP:NASDAQ)

NRx Pharmaceuticals (NRXP) stock gains as the FDA approves its generic ketamine injection,...

Yesterday MSN

NRx Pharmaceuticals (NRXP) stock jumps over 26% after hours: What's behind the surge?

NRx Pharmaceuticals Inc. NRXP shares jumped 26.69% to $3.37 in after-hours trading Thursday after the company said it will ...

October 15 WFMZ

NRx Pharmaceuticals Announces the Appointment of Stephen Willard, Chief Executive Officer and Director | PR Newswire | wfmz.com

By NRx Pharmaceuticals, Inc., H.C. Wainwright & Co. 24th Annual Global Investment Conference ... This content is provided by PR Newswire. For questions or concerns...

September 29 GlobeNewswire

NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

NRX-101, the investigational drug to be tested in this trial was originally conceived by NRx Pharmaceuticals as a Breakthrough therapy drug for treatment of suicidal...

Never miss news about NRx

Track NRx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

NRx competitors & trending companies

Browse news for competitors to NRx and other trending companies.